KBC Group NV Trims Stake in Cigna Group $CI

KBC Group NV reduced its stake in Cigna Group (NYSE:CI) by 9.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 359,236 shares of the health services provider’s stock after selling 38,820 shares during the period. KBC Group NV’s holdings in Cigna Group were worth $98,873,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of CI. Massachusetts Financial Services Co. MA grew its holdings in shares of Cigna Group by 8.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after acquiring an additional 903,334 shares during the period. Dodge & Cox lifted its stake in shares of Cigna Group by 4.0% in the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after purchasing an additional 354,615 shares during the period. Sanders Capital LLC boosted its position in shares of Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after purchasing an additional 35,150 shares in the last quarter. Capital Research Global Investors grew its stake in Cigna Group by 140.2% in the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after purchasing an additional 1,855,897 shares during the period. Finally, Arrowstreet Capital Limited Partnership grew its stake in Cigna Group by 7.4% in the third quarter. Arrowstreet Capital Limited Partnership now owns 2,695,620 shares of the health services provider’s stock worth $777,012,000 after purchasing an additional 186,880 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CI shares. Piper Sandler lowered their price objective on Cigna Group from $374.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Mizuho set a $325.00 price target on shares of Cigna Group in a research note on Friday, January 9th. Royal Bank Of Canada lowered their price target on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Jefferies Financial Group boosted their price objective on shares of Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Finally, Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $332.63.

Cigna Group Trading Down 1.3%

NYSE CI opened at $269.01 on Thursday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The stock’s fifty day moving average price is $276.32 and its 200-day moving average price is $278.23. The stock has a market cap of $70.89 billion, a P/E ratio of 12.13, a P/E/G ratio of 0.94 and a beta of 0.26.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.During the same quarter in the previous year, the firm earned $6.64 EPS. Cigna Group’s quarterly revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th were paid a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. The ex-dividend date was Thursday, March 5th. Cigna Group’s payout ratio is currently 28.13%.

Insider Buying and Selling

In other news, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Everett Neville sold 1,719 shares of the firm’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This trade represents a 23.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.